The process of creating new medications to cure illnesses in humans is costly, difficult, and time-consuming. A new medication can cost up to $2.5 billion and take up to 15 years to reach the market.
Our clients in the biopharmaceutical and biotech sectors have put their trust in us to further their studies. Our therapeutic area expertise includes established medication disease markets like oncology and hematology/oncology as well as chronic disorders. It also includes emerging R&D innovation areas like immuno-oncology, biomarkers, and rare diseases.
KLCRO provides the knowledge and experience required to plan, organize, and carry out your clinical trials with skill, accuracy, and a steadfast commitment to quality at every step of the drug development process.
LEARN MORE ABOUT OUR THERAPEUTIC EXPERIENCE
Biosimilar Development
Biosimilar Development
KLCRO has the proven expertise to help you.
Cardiovascular
Cardiovascular
Experience across a broad range of indications and an investigator network.
Gastroenterology
Gastroenterology
Extensive knowledge of Gastroenterology.
Critical Care
Critical Care
We understand the unique nature of clinical studies in a critical care environment.
Oncology and Hematology
Oncology and Hematology
Extensive knowledge of Oncology and Hematology research.
Infectious Diseases
Infectious Diseases
KLCRO Infectious Disease CRO delivers the data you need to support your clinical.